SHAHRIAR DADKHAH

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease LINCOLNWOOD, IL NPI 1063469641

General Payments — all program years on this page

$47,709.32

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 196
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $379.52 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $379.5216

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $24,726.2358
2019 $21,193.3956
2020 $357.2017
2021 $234.5412
2022 $388.7517
2023 $429.6920
2024 $379.5216

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1081705605 Lexicon Pharmaceuticals, Inc. $23.09 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081705607 Lexicon Pharmaceuticals, Inc. $26.23 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081705609 Lexicon Pharmaceuticals, Inc. $27.51 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086907503 Novartis Pharmaceuticals Corporation $14.59 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086907515 Novartis Pharmaceuticals Corporation $20.63 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086907517 Novartis Pharmaceuticals Corporation $30.19 11/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086907519 Novartis Pharmaceuticals Corporation $27.22 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101385436 E.R. Squibb & Sons, L.L.C. $31.63 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101385458 E.R. Squibb & Sons, L.L.C. $29.68 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101385476 E.R. Squibb & Sons, L.L.C. $21.74 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115547116 Amgen Inc. $22.56 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115547123 Amgen Inc. $22.85 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115547129 Amgen Inc. $23.14 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117857591 Boehringer Ingelheim Pharmaceuticals, Inc. $18.34 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117857593 Boehringer Ingelheim Pharmaceuticals, Inc. $24.17 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154884490 Kiniksa Pharmaceuticals International, plc $15.95 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.